Skip to main content
STARPHARMA HOLDINGS LIMITED logo

STARPHARMA HOLDINGS LIMITED — Investor Relations & Filings

Ticker · SPL ISIN · AU000000SPL0 LEI · 254900WRGE3OUSWGMB55 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,316 across all filing types
Latest filing 2024-07-01 Share Issue/Capital Cha…
Country AU Australia
Listing ASX SPL

About STARPHARMA HOLDINGS LIMITED

https://starpharma.com/

Starpharma Holdings Limited is a biopharmaceutical company focused on the development of dendrimer technology for pharmaceutical and life science applications. The company utilizes its proprietary DEP® (Dendrimer Enhanced Product) delivery platform to improve the performance of existing drugs by enhancing solubility, reducing toxicity, and providing targeted delivery. Its clinical-stage internal pipeline includes DEP® docetaxel, DEP® cabazitaxel, and DEP® irinotecan, primarily targeting oncology. Starpharma also markets VivaGel® BV, a non-antibiotic treatment and prevention for bacterial vaginosis, and VIRALEZE™, an antiviral nasal spray containing astodrimer sodium. The company collaborates with global pharmaceutical firms to apply its dendrimer technology to various therapeutic areas, including antibody-drug conjugates and radiopharmaceuticals.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - SPL 8 pages 23.6KB
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Starpharma Holdings Limited regarding the quotation of securities issued under an employee incentive scheme. It details the number and type of securities to be quoted, issue dates, and confirms that these securities are being issued pursuant to an employee share plan and performance rights plan. There is no financial report, earnings data, or management discussion. The document is a formal notification to the ASX about new securities to be quoted, consistent with announcements about share issues or capital changes. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief report publication announcement or a regulatory filing fallback. Confidence is high due to clear references to securities issuance and quotation under employee incentive schemes.
2024-07-01 English
Change in substantial holding 4 pages 228.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001 Section 671B, titled 'Notice of change of interests of substantial holder'. It details changes in voting power and relevant interests of a substantial shareholder (Allan Gray Australia Pty Ltd and related bodies corporate) in Starpharma Holdings Limited. The document includes tables listing related bodies corporate, funds managed, changes in relevant interests, and present relevant interests. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category 'Major Shareholding Notification' (MRQ). The document is substantive and not merely an announcement or certification, and it does not fit other categories such as director dealings or capital changes. Therefore, the correct classification is MRQ with high confidence.
2024-07-01 English
Change in Director's Interest Notice - Jeff Davies 2 pages 200.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's acquisition of shares, including the number of securities held before and after the change, the date of change, and the nature of the transaction (on-market purchase). The document is a formal notification of a director's personal share transactions. It does not contain financial statements, management discussion, or other report content. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3300 characters, consistent with a short notice rather than a full report. Therefore, the correct classification is DIRS.
2024-06-30 English
Change in substantial holding 7 pages 114.5KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001 Section 671B. It details changes in voting power and relevant interests of a substantial shareholder in Starpharma Holdings Limited. The content includes dates of changes, nature of changes, and voting power percentages. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory disclosure about shareholding changes.
2024-06-27 English
Change in Director's Interest Notice - R Thomas 2 pages 243.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director's Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including number of shares held before and after the change, nature of the transaction, and value. There is no financial performance data, earnings information, or report content. This is a notification of personal share transactions by a company director, which fits the definition of Director's Dealing filings.
2024-06-26 English
Change in Director's Interest Notice - L Cheng 2 pages 207.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details a director's change in shareholding, including the number of shares acquired, disposed, and held before and after the change. The document is a formal notification of a director's personal share transactions. It does not contain financial performance data, management discussion, or other report content. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3420 characters, consistent with a short notice rather than a full report. Therefore, the correct classification is DIRS with high confidence.
2024-06-26 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.